CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis
Müller F, Atreya R, Völkl S, Aigner M, Kretschmann S, Kharboutli S, Leppkes M, Sitte S, Strobel D, Hartmann A, Mehandru S, Colombel JF, Schett G, Mackensen A, Neurath M (2025)
Publication Type: Journal article
Publication year: 2025
Journal
Book Volume: 393
Pages Range: 1239-1241
Journal Issue: 12
DOI: 10.1056/NEJMc2508023
Authors with CRIS profile
Fabian Müller
Professur für CAR-T-Zell-Therapie
Raja Atreya
Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen
Simon Völkl
Department of Medicine 5 – Haematology and Oncology
Sascha Kretschmann
Department of Medicine 5 – Haematology and Oncology
Moritz Leppkes
Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology
Selina Sitte
Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology
Deike Strobel
Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology
Arndt Hartmann
Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie
Georg Schett
Lehrstuhl für Innere Medizin III
Andreas Mackensen
Lehrstuhl für Innere Medizin V
Markus Neurath
Lehrstuhl für Innere Medizin I (Medizin 1)
Involved external institutions
United States (USA) (US)How to cite
APA:
Müller, F., Atreya, R., Völkl, S., Aigner, M., Kretschmann, S., Kharboutli, S.,... Neurath, M. (2025). CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis. New England Journal of Medicine, 393(12), 1239-1241. https://doi.org/10.1056/NEJMc2508023
MLA:
Müller, Fabian, et al. "CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis." New England Journal of Medicine 393.12 (2025): 1239-1241.
BibTeX: Download